Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
951 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Condition: Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Radium-223 dichloride;   Drug: cabazitaxel;   Drug: Carboplatin;   Drug: Enzalutamide
22 Recruiting Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment
Condition: Urinary Incontinence, Stress
Interventions: Procedure: AMS-800;   Procedure: ADVANCE/ADVANCEXP;   Procedure: VIRTUE;   Procedure: INVANCE
23 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
24 Not yet recruiting PSMA PET/CT for Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Drug: PSMA PET/CT scan
25 Not yet recruiting Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
Condition: Recurrent Prostate Carcinoma
Interventions: Radiation: High-Dose Rate Brachytherapy;   Procedure: Hyperthermia Treatment
26 Not yet recruiting Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )
Condition: Prostatic Neoplasms, Castration-Resistant
Intervention: Drug: Xofigo (Radium-223 dichloride, BAY88-8223
27 Recruiting Trans-MAPP II Study of Urologic Chronic Pelvin Pain
Conditions: Interstitial Cystitis;   Chronic Prostatitis
Intervention:
28 Recruiting Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study
Conditions: Prostate Cancer;   Androgen-deprivation Therapy
Intervention: Other: Standard care
29 Not yet recruiting Olaparib With or Without Cediranib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation;   Prostate Carcinoma Metastatic in the Bone;   Prostate Small Cell Carcinoma;   Stage IV Prostate Adenocarcinoma
Interventions: Drug: Cediranib;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib
30 Not yet recruiting Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201
Condition: Prostate Cancer
Interventions: Drug: SoluMatrix™ Abiraterone Acetate;   Drug: Methylprednisolone
31 Not yet recruiting Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Drug: Trametinib
32 Recruiting Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ System
Condition: Cancer of the Prostate
Intervention:
33 Recruiting Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma
Condition: Bone Metastasis
Intervention: Procedure: Sodium fluoride PET
34 Recruiting Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer
Condition: Prostate Cancer
Interventions: Other: geriatric assessment and quality of life;   Radiation: Radiotherapy
35 Recruiting Prospective Evaluation of Hypofractionation Proton Beam Therapy With Concurrent Treatment of the Prostate and Pelvic Nodes for Clinically Localized, High Risk or Unfavorable Intermediate Risk Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: Hypofractionation Proton beam therapy with Concurrent Treatment of the Prostate and Pelvic Nodes
36 Recruiting Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers
Condition: Benign Prostate Hyperplasia
Intervention: Other: Prostate biopsy, prostatectomy or prostate resection
37 Recruiting Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education
Condition: Prostate Cancer
Intervention: Behavioral: MBSR
38 Recruiting Transrectal Ultrasound Robot-Assisted Prostate Biopsy
Condition: Prostate Cancer
Intervention: Device: TRUS-Robot
39 Recruiting Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Device: Embosphere® (Prostatic Arteries Embolization);   Drug: Drug therapy
40 Recruiting Institut Paoli Calmettes Prostate Cancer Database
Condition: Prostatic Neoplasms
Intervention: Other: Data collection

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years